The Prominent Foresite Capital CEO Jim Tananbaum

Jim Tananbaum is the new CEO of the Forest Capital, an equity firm specializing in healthcare. He ranks position 52 among the top 100 Tech Investors. He has been in the top leadership for over 25 years with intensive expertise in healthcare entrepreneurial. He is the principal architect of Foresite Capital Company’s investment structure and has played a key role in various Foresite Capital Companies.

Previously, he was the co-founder of GelTex Pharmaceuticals, a company that managed to raise about $1.6 billion from two drugs. Its prominent drug, Renagel (Renzela) could bring annual revenue of $200 million. Currently, this drug produces approximately $1billion after being on the market for 22 years. He was also the co-founder and CEO of Theravance, Inc. Jim of Facebook, The company used a joint venture between Theravance Biopharma (NASDAQ: TBPH), Inc. and Innoviva (NASDAQ: INVA). These two companies have had a combined market capital of approximately $3.2 billion. His success in the financing of healthcare sector has been significant and more learn about Jim.

Jim Tananbaum went to Yale University where he graduated with BS/BSEE and later joined Harvard University where he earned M.B.A and M.D. He was a member of both the advisory board and visiting committees in Harvard-MIT HST program as well as on the Yale’s President Advisory Council. Jim Tanabaum also attended the Massachusetts Institute of Technology where he got an M.S. The Foresite Capital offers funds for expansion to the future healthcare managers. They provide their products and services to all private and public markets. The Foresite Capital is in San Francisco with its central office in New York. Earlier on, Jim Tananbaum founded the Prospect Venture Partners II and III which boosted his expertise in investment. He has been a key leader in several investments like the Amira Pharmaceuticals which was later acquired by NYSE: BMS, Jazz Pharmaceuticals, Amerigroup, and Healtheon. He purposely founded the Foresite Capital aiming to hitch the elements of various aspects of his career to create a new investment platform. Jim Tananbaum has had a remarkable impact on financing the healthcare sector. His professional achievement has been critical to the success of Foresite Capital and read full article.

More visit: https://twitter.com/foresitecap

Leave a Reply

Your email address will not be published. Required fields are marked *